ASSOCIATION OF FIB4 SCORE WITH DISEASE PROGRESSION IN REAL-WORLD POPULATIONS DIAGNOSED WITH NAFLD/NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE

被引:0
|
作者
Lai, Michelle
Broestl, Jeremy
Frick, Andrew
Haubrich, Richard
Koch, Bruce
Milligan, Scott
Natha, Macky
Younossi, Zobair M.
Afdhal, Nezam H.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1474
引用
收藏
页码:S1416 / S1416
页数:1
相关论文
共 50 条
  • [41] HEPATORENAL SYNDROME-ACUTE KIDNEY INJURY PATIENT CHARACTERISTICS, TREATMENT, AND CLINICAL RESPONSE BY DISEASE SEVERITY IN US: REAL-WORLD PRACTICE PATTERNS FROM 11 US HOSPITALS
    Sanyal, Arun J.
    Reddy, K. Rajender
    Brown, Kimberly Ann
    Landis, Charles
    Cullaro, Giuseppe
    Huang, Xingyue
    Corman, Shelby
    Kelkar, Sneha
    Kebede, Nehemiah
    Raina, Rutika
    Edmundson, Patrick
    Jamil, Khurram
    Allegretti, Andrew
    HEPATOLOGY, 2021, 74 : 1190A - 1190A
  • [42] An Association of Framingham Risk Score with Patient Determined Disease Steps in a Cohort of Relapsing-Remitting Multiple Sclerosis Patients: An Italian Real-World Monocentric Experience
    Zanghi, Aurora
    Di Filippo, Paola Sofia
    Avolio, Carlo
    D'Amico, Emanuele
    CURRENT NEUROPHARMACOLOGY, 2025, 23 (03) : 310 - 316
  • [43] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database
    Tacke, Frank
    Tanios, Fady
    Xie, Lin
    Malhotra, Deepa
    Dagenais, Simon
    Katchiuri, Nino
    Emir, Birol
    JOURNAL OF HEPATOLOGY, 2022, 77 : S151 - S151
  • [44] Real-World Clinical Burden of Sickle Cell Disease in the US Community-Practice Setting: A Single-Center Experience from the Foundation for Sickle Cell Disease Research
    Bronte-Hall, Lanetta
    Parkin, Matthew
    Green, Courtney
    Tchouambou, Elsa
    Huynh, Lynn
    Puri-Sharma, Charu
    Chang, Rose
    Chawla, Anjulika
    Signorovitch, James
    Blyden, Gershwin Theophilus
    BLOOD, 2019, 134
  • [45] The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical practice in the US
    Wenhui Wei
    Emma Sullivan
    Stuart Blackburn
    Chieh-I Chen
    James Piercy
    Jeffrey R. Curtis
    BMC Rheumatology, 3
  • [46] The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical practice in the US
    Wei, Wenhui
    Sullivan, Emma
    Blackburn, Stuart
    Chen, Chieh-, I
    Piercy, James
    Curtis, Jeffrey R.
    BMC RHEUMATOLOGY, 2019, 3 (01)
  • [47] Predicted Coronary Heart Disease Risk Reduction and Dual Blood Pressure/Cholesterol Goal Attainment in Patients With Hypertension Treated in Real-World Clinical Practice
    Neutel, Joel M.
    Eaddy, Michael
    Lunacsek, Orsolya E.
    Roberts, Craig
    Chen, Linda
    Kean, Allison J.
    Jackson, James H.
    JOURNAL OF CLINICAL HYPERTENSION, 2010, 12 (06): : 396 - 406
  • [48] Real-World Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Luspatercept: An Evaluation of US Clinical Practice Utilization and Treatment Patterns
    Mukherjee, Sudipto
    Brown-Bickerstaff, Cherrishe
    McBride, Ali
    Gajra, Ajeet
    Gentile, Danielle
    Falkenstein, Angelica
    Miller, Talia
    Laney, JaLyna
    Savill, Kristin M.
    Makinde, Adeola Y.
    BLOOD, 2022, 140
  • [49] A 2-step fast-track elastometry service for advanced workup of nonalcoholic fatty liver disease (NAFLD) patients - single-center real-world experience of outpatient clinical practice
    Alsenbesy, Mohamed
    Rau, Monika
    Weiss, Johannes
    Goetze, Oliver
    Geier, Andreas
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (10): : 1209 - 1217
  • [50] Association of Clinical Characteristics at Diagnosis with Outcomes in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from a Real-World Medical Chart Review in the US
    Mukherjee, Sudipto
    Savill, Kristin M.
    Gajra, Ajeet
    Gentile, Danielle
    Falkenstein, Angelica
    Miller, Talia
    Laney, JaLyna
    McBride, Ali
    BLOOD, 2022, 140 : 10998 - 11000